RecruitingNot ApplicableNCT06689878

Mobile Cognitive Behavioral Therapy for Stroke


Sponsor

Weill Medical College of Cornell University

Enrollment

10 participants

Start Date

Feb 25, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to assess the feasibility and acceptability of "MAYA", a mobile cognitive behavioral therapy app for anxiety and mood disorders, in adults who have had a stroke.


Eligibility

Min Age: 40 YearsMax Age: 79 Years

Inclusion Criteria9

  • Age 40-79
  • Presence of clinically-significant anxiety and/or depression (as determined by an eligibility evaluation)
  • Stroke that occurred 1 month or more prior to study initiation
  • Capacity to provide consent
  • No greater than mild cognitive difficulties based on an eligibility evaluation conducted as part of the study
  • If taking medication for depression and/or anxiety, must be on a stable dose for a minimum of 8 weeks prior to study initiation
  • Ability to use iPhone or iPad independently
  • Home internet access
  • Willingness to participate in the full study duration.

Exclusion Criteria8

  • Aphasia of moderate or greater severity (as determined during an eligibility evaluation)
  • Non-fluency in English
  • History of a bipolar or psychotic disorder
  • Current alcohol or substance use disorder
  • Active suicidal ideation
  • Current engagement in psychotherapy is not grounds for exclusion unless the individual's psychotherapy is primarily focused on CBT
  • Severe depression and/or anxiety based on the initial evaluation and clinical judgment of the study doctor, which warrants a higher level of care and/or immediate referral to psychiatric services
  • Any other clinical or medical reason in the study doctor's initial screening evaluation that suggests the study is not appropriate for the participant

Interventions

BEHAVIORALMobile Cognitive Behavioral App

A mobile cognitive behavioral therapy (CBT) app called "Maya" that includes modules with educational content and teaching and practice of strategies that address depression and anxiety after stroke.


Locations(1)

Weill Cornell Medicine

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06689878


Related Trials